STOCK TITAN

Our Work Is Helping Quest Land on Some Noteworthy Lists

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Quest Diagnostics (Ticker: QUEST) has received significant recognition in 2023, appearing on influential lists such as FORTUNE Magazine's 'World's Most Admired Companies' and others honoring inclusion & diversity, environmental sustainability, and innovation. This recognition has positively impacted Quest's reputation, as measured by public surveys.
Positive
  • None.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / November 13, 2023 / Quest Diagnostics

Quest has been getting a lot of recognition lately and is showing up on a number of influential lists.

The recognition began earlier this year with our ninth straight appearance on FORTUNE Magazine's 2023 "World's Most Admired Companies" list. So far in 2023, we've also been recognized on the following prestigious lists that honor companies for their work in areas like inclusion & diversity and environmental sustainability:

All this recognition is definitely helping Quest's reputation. We know that because we measure our reputation based on surveys with members of the public who know something about us.

"It feels great to be part of a company with a strong reputation that is committed to operating responsibly and with high integrity," said Cecilia McKenney, Senior Vice President and Chief Human Resources Officer. "Our colleagues were healthcare heroes during the pandemic, and now they're bringing our purpose to life by working together to create a healthier world, one life at a time."

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics



View source version on accesswire.com:
https://www.accesswire.com/802783/our-work-is-helping-quest-land-on-some-noteworthy-lists

FAQ

What influential lists has Quest Diagnostics appeared on in 2023?

Quest Diagnostics has appeared on influential lists such as FORTUNE Magazine's 'World's Most Admired Companies', Most Trustworthy Companies in America (Newsweek), World's Best Companies (Time Magazine), and others.

How does Quest Diagnostics measure its reputation?

Quest Diagnostics measures its reputation based on surveys with members of the public who are knowledgeable about the company.

Why is the recognition important for Quest Diagnostics?

The recognition is important for Quest Diagnostics as it positively impacts the company's reputation and public perception.

How has the recognition impacted Quest Diagnostics?

The recognition has positively impacted Quest Diagnostics' reputation, as measured by public surveys.

What areas has Quest Diagnostics been recognized for?

Quest Diagnostics has been recognized for its work in areas such as inclusion & diversity, environmental sustainability, innovation, and workplace practices.

Who has honored Quest Diagnostics for the percentage of Board of Director seats held by women?

Executive Women of New Jersey and Women's Forum of New York both recently honored Quest Diagnostics for the percentage of Board of Director seats held by women.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

15.26B
109.71M
0.43%
91.73%
2.29%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SECAUCUS

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator